DESMOID FIBROMATOSIS
Clinical trials for DESMOID FIBROMATOSIS explained in plain language.
Never miss a new study
Get alerted when new DESMOID FIBROMATOSIS trials appear
Sign up with your email to follow new studies for DESMOID FIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug may halt rare tumor growth in kids
Disease control OngoingThis study tests a drug called nirogacestat in children and teens with desmoid tumors that have grown despite prior treatment and cannot be surgically removed. The goal is to see if the drug can stop or slow tumor growth and to check for side effects. About 31 participants aged 1…
Matched conditions: DESMOID FIBROMATOSIS
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 26, 2026 09:31 UTC
-
Immunotherapy duo takes on rare tumors in nationwide trial
Disease control OngoingThis study tests two immunotherapy drugs, nivolumab and ipilimumab, in adults with over 50 types of rare cancers. The goal is to see if this drug combination can shrink tumors or stop them from growing. The trial is no longer enrolling new participants, but results will help guid…
Matched conditions: DESMOID FIBROMATOSIS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:28 UTC
-
Electric shock therapy for tumors? study pulled before it started
Disease control TerminatedThis study planned to see if electrochemotherapy (using electric pulses to help chemotherapy enter cells) could shrink desmoid tumors and ease symptoms. It was designed for people with growing, painful tumors who couldn't have surgery or other treatments. However, the study was w…
Matched conditions: DESMOID FIBROMATOSIS
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated May 20, 2026 11:57 UTC